Article metrics

Download PDFPDF

430 A phase II study of nivolumab + BMS-986016 (relatlimab) in patients with metastatic uveal melanoma(UM) (CA224–094)

 

Online download statistics by month:

Online download statistics by month: November 2020 to August 2024

AbstractFullPdf
Nov 2020123024
Dec 20203207
Jan 20215608
Feb 2021124011
Mar 2021256027
Apr 2021136014
May 202141017
Jun 20210016
Jul 20210017
Aug 20210010
Sep 20210010
Oct 2021124034
Nov 202176025
Dec 202110008
Jan 2022130014
Feb 20228806
Mar 2022142014
Apr 2022112012
May 20226007
Jun 20227003
Jul 20225801
Aug 20224809
Sep 20226805
Oct 20226803
Nov 20226806
Dec 20225404
Jan 20232601
Feb 20237405
Mar 20237801
Apr 20236602
May 20234802
Jun 20235407
Jul 20237005
Aug 20235402
Sep 20234203
Oct 20236409
Nov 20235403
Dec 20235802
Jan 20242000
Feb 20242201
Mar 20243803
Apr 20247204
May 20242801
Jun 20241600
Jul 20242202
Aug 20242202
Total29620367